Posted inBusiness
Protheragen Introduces Disease Model Development Platform to Empower Rare Disease Therapy Research
Protheragen, a leading CRO in rare disease research, is proud to announce the launch of its groundbreaking disease model development platform. This platform is specifically designed to develop 2D cell…